UAS regulatory sequences drive expression of the extracellular and transmembrane domains of kek1 fused to the entire Egfr cytoplasmic domain. A G901R mutation (which disrupts ATP binding) has been introduced within the Egfr kinase domain, abolishing kinase activity. The chimeric protein is tagged at the C-terminal end with GFP.